Insider · CIK 0001869527
Gloria F Basse
Files at ICCC (IMMUCELL CORP /DE/). First filing -, latest -.
In brief
Gloria F Basse files SEC Form 4 as director at ICCC (IMMUCELL CORP /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gloria F Basse has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | ICCC IMMUCELL CORP /DE/ | AGrant or award Non Qualified Stock Options (Right to buy)derivative | +11,933 | $0.00 | $0 | 11,933 | Apr 16, 2026 |
| Apr 16, 2025 | ICCC IMMUCELL CORP /DE/ | AGrant or award Non Qualified Stock Options (Right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Apr 14, 2026 |
| Jun 11, 2025 | ICCC IMMUCELL CORP /DE/ | MOption exercise Common stock $0.10 per value per share | +3,530 | $4.81 | $17k | 3,530 | Jun 13, 2025 |
| Jun 11, 2025 | ICCC IMMUCELL CORP /DE/ | MOption exercise Non Qualified Stock Options (Right to buy)derivative | -11,470 | $0.00 | $0 | 3,530 | Jun 13, 2025 |
| Jun 11, 2025 | ICCC IMMUCELL CORP /DE/ | MOption exercise Non Qualified Stock Options (Right to buy)derivative | -4 | $0.00 | $0 | 0 | Jun 13, 2025 |
Questions about Gloria F Basse
Answered from the filings on this page, as of the latest one.
Is Gloria F Basse buying or selling?
Gloria F Basse has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gloria F Basse's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gloria F Basse has 0.
Where does Gloria F Basse file Form 4?
Gloria F Basse has filed Form 4 at ICCC (IMMUCELL CORP /DE/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.